Rocket


Overview
Financials
News + Filings

 
 

Greenwich LifeSciences, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-19Dec-31-18
Revenues2,6061,270
            Revenue growth105.2% 
Cost of goods sold3,4251,690
Gross profit-819-420
            Gross margin-31.4%-33.0%
General and administrative819420
EBITA-3,422-1,686
            EBITA margin-131.3%-132.8%
Amortization of intangibles44
EBIT-3,425-1,690
            EBIT margin-131.4%-133.0%
Pre-tax income-3,425-1,690
Income taxes00
            Tax rate0.0%0.0%
Net income-3,425-1,690
            Net margin-131.4%-133.0%
 
Diluted EPS($0.57)($3.12)
Shares outstanding (diluted)6,029542
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy